Synapse - David Spriggs

Search Within

David R Spriggs

Results (72)

A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel (Tax), IP cisplatin (Cis), and IV bevacizumab (Bev) as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer

Meeting Abstract

Konner, J. A.; Fallon, K.; Pezzuli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Chiang, A.; Tew, W.; Spriggs, D.; Aghajanian, C.
Journal of Clinical Oncology (2007)

Fulltext@MSK | Save

Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer

Journal Article

Sabbatini, P. J.; Ragupathi, G.; Hood, C.; Aghajanian, C. A.; Juretzka, M.; Iasonos, A.; Hensley, M. L.; Spassova, M. K.; Ouerfelli, O.; Spriggs, D. R.; more...
Clinical Cancer Research (2007)

Fulltext@MSK | Save

Early CA-125 fluctuations in patients with recurrent ovarian cancer receiving chemotherapy

Journal Article

Sabbatini, P.; Mooney, D.; Iasonos, A.; Thaler, H.; Aghajanian, C.; Hensley, M.; Konner, J.; Spriggs, D.; Abu-Rustum, N. R.; Dupont, J.
International Journal of Gynecological Cancer (2007)

Fulltext@MSK | Save

A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission

Journal Article

Levine, D.; Park, K.; Juretzka, M.; Esch, J.; Hensley, M.; Aghajanian, C.; Lewin, S.; Konner, J.; Derosa, F.; Spriggs, D.; more...
Cancer (2007)

Fulltext@MSK | Save

A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer

Journal Article

Leiser, A. L.; Maluf, F. C.; Chi, D. S.; Sabbatini, P.; Hensley, M. L.; Schwartz, L.; Venkatraman, E.; Spriggs, D.; Aghajanian, C.
International Journal of Gynecological Cancer (2007)

Fulltext@MSK | Save

CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy

Journal Article

Juretzka, M. M.; Barakat, R. R.; Chi, D. S.; Iasonos, A.; Dupont, J.; Abu-Rustum, N. R.; Poynor, E. A.; Aghajanian, C.; Spriggs, D.; Hensley, M. L.; more...
Gynecologic Oncology (2007)

Fulltext@MSK | Save

A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors

Journal Article

Hensley, M. L.; Dizon, D.; Derosa, F.; Venkatraman, E.; Sabbatini, P.; Chi, D. S.; Dupont, J.; Colevas, A. D.; Spriggs, D.; Aghajanian, C.
Investigational New Drugs (2007)

Fulltext@MSK | Save

Duration of second or greater complete clinical remission in ovarian cancer: Exploring potential endpoints for clinical trials

Journal Article

Harrison, M. L.; Gore, M. E.; Spriggs, D.; Kaye, S.; Iasonos, A.; Hensley, M.; Aghajanian, C.; Venkatraman, E.; Sabbatini, P.
Gynecologic Oncology (2007)

Fulltext@MSK | Save

Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer

Journal Article

Diefenbach, C. S. M.; Shah, Z.; Iasonos, A.; Barakat, R. R.; Levine, D. A.; Aghajanian, C.; Sabbatini, P.; Hensley, M. L.; Konner, J.; Tew, W.; more...
Gynecologic Oncology (2007)

Fulltext@MSK | Save

Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer

Journal Article

Sabbatini, P.; Dupont, J.; Aghajanian, C.; Derosa, F.; Poynor, E.; Anderson, S.; Hensley, M.; Livingston, P.; Iasonos, A.; Spriggs, D.; more...
Clinical Cancer Research (2006)

Fulltext@MSK | Save